1. Author(s), Institution
Title
Author(s), Institution
Introduction
Results
Conclusions
Reporting of the emergence of echinocandin resistant Candida glabrata is increasing worldwide, with antifungal usage often being the major factor.  Our facility’s incidence of C. glabrata rose from 21% of all Candida sp. bloodstream
Reporting of the emergence of echinocandin resistant Candida glabrata is increasing worldwide, with antifungal usage often being the major factor.  Our facility’s incidence of C. glabrata rose from 21% of all Candida sp. bloodstreamReporting of the emergence of echinocandin resistant Candida glabrata is increasing worldwide, with antifungal usage often being the major factor.  Our facility’s incidence of C. glabrata rose from 21% of all Candida sp. bloodstream
Reporting of the emergence of echinocandin resistant Candida glabrata is increasing worldwide, with antifungal usage often being the major factor.  Our facility’s incidence of C.
Reporting of the emergence of echinocandin resistant Candida glabrata is increasing worldwide, with antifungal usage often being the major factor.  Our facility’s incidence of C. glabrata rose from 21% of all Candida sp. bloodstream infections in 2009 to 37% by   Due to this increase, we assessed our usage of antifungals and its impact on the acquisition of the fks1 hotspot (HS) mutation in C. glabrata.
Methods
Discussion
Reporting of the emergence of echinocandin resistant Candida glabrata is increasing worldwide, with antifungal usage often being the major factor.  Our facility’s incidence of C. glabrata rose from 21% of all Candida sp. bloodstream infections in 2009 to 37% by  
Reporting of the emergence of echinocandin resistant Candida glabrata is increasing worldwide, with antifungal usage often being the major factor.  Our facility’s incidence of C. glabrata rose from 21% of all Candida sp. bloodstream infections in 2009 to 37% by   Due to this increase, we assessed our usage of antifungals and its impact on the acquisition of the fks1 hotspot (HS) mutation in C. glabrata.  Due to this increase, we assessed our usage of antifungals and its impact on the acquisition of the fks1 hotspot (HS) mutation in C. glabrata.
References
Reporting of the emergence of echinocandin resistant Candida glabrata is increasing worldwide, with antifungal usage often being the major factor.  Our facility’s incidence of C. glabrata rose from 21% of all Candida sp. Bloodstream